Skip to content
AnalystLens

CHURCH & DWIGHT CO INC /DE/ Quarterly Report for Q2 Ended Jun 30, 2015

Filing Date
Filed August 4, 2015
Period End
June 30, 2015
Security
CHD
One revenue dollarkept$0.09
In the record · 2016–202610-K1110-Q328-K103

CHD filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 103 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Aug ’19Aug ’19
  3. Leadership change8-K · Sep ’21Sep ’21
  4. Material agreement8-K · Jul ’25Jul ’25

Summary

Summary of the 10-Q filed August 4, 2015. Cited figures are marked; the original filing is the authoritative source.

Church & Dwight Co., Inc. (CHD) reported solid top-line growth in the second quarter and first half of 2015, with net sales increasing by 4.8%a and 4.3% respectively, driven by volume increases and favorable price/mix across its segments.

The acquisitions of Lil' Drug Store Brands and Varied Industries Corporation contributed to this growth, particularly in the Consumer Domestic and Specialty Products Divisions (SPD). Despite increased sales, profitability faced some headwinds. Gross margin saw a slight decrease in Q2 due to higher manufacturing costs, including start-up costs for a new vitamin facility, and unfavorable foreign exchange rates, though partially offset by lower commodity costs and acquisition benefits.

Selling, General & Administrative (SG&A) expenses increased due to a pension plan settlement charge and acquisition-related costs. A significant event was the $17.0 millionb impairment charge related to the investment in Natronx, which impacted equity in earnings of affiliates and contributed to a higher effective tax rate. Financially, the company demonstrated strong operating cash flow generation, which increased by 20.5% year-over-year for the first six months.

Management is focused on optimizing working capital and expects sufficient cash to cover capital expenditures, dividends, and debt obligations, including the repayment of maturing senior notes. Shareholder returns were supported by an increased quarterly dividend and ongoing share repurchase programs.

Key Highlights

  1. Net sales increased by 4.8% to $847.1 million in Q2 2015 and by 4.3% to $1,659.4 million in the first six months of 2015, driven by volume and favorable price/mix across segments, with contributions from recent acquisitions.
  2. Gross profit increased in both periods, though gross margin experienced a slight decline in Q2 due to higher manufacturing costs (including vitamin facility start-up costs) and unfavorable foreign exchange, partially offset by lower commodity costs and acquisition benefits.
  3. SG&A expenses rose due to an $8.9 million pension settlement charge and costs associated with the LDS and VI-COR acquisitions.
  4. The company recorded a $17.0 million impairment charge on its investment in Natronx, significantly impacting equity in earnings from affiliates.
  5. Net cash provided by operating activities increased by 20.5% to $248.4 million for the first six months of 2015 compared to the prior year.
  6. The company repurchased shares under its share repurchase programs and increased its quarterly dividend by 8% to $0.335 per share.
  7. Cash and cash equivalents decreased to $203.2 million from $423.0 million at year-end 2014, partly due to cash used in investing activities for acquisitions and capital expenditures, and financing activities including share repurchases and dividend payments.

Follow one dollar

Of each $1.00 of revenue in Q2 FY2015, Church & Dwight Co Inc kept $0.09.

  1. Revenue$847.1M100.0%
  2. Cost of revenue−$474.0M56.0%
  3. Gross profit$373.1M44.0%
  4. Operating costs−$230.8M27.2%
  5. Operating income$142.3M16.8%
  6. Interest, other & tax−$68.6M8.1%
  7. Net income$73.7M8.7%
Computed from 10-QQ2 FY2015filed August 4, 2015Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q2 FY2015 against Q2 FY2014

Line itemQ2 FY2015Q2 FY2014Change
Revenue$847.10M$808.30M+4.8%
Cost of Revenue$474.00M$451.90M+4.9%
Gross Profit$373.10M$356.40M+4.7%
R&D Expenses$18.30M$14.40M+27.1%
SG&A Expenses$115.00M$104.80M+9.7%
Operating Income$142.30M$138.20M+3.0%
Interest Expense$7.90M$6.90M+14.5%
Net Income$73.70M$88.80M−17.0%
EPS (Basic)$0.28$0.33−15.2%
EPS (Diluted)$0.28$0.33−13.8%
Shares Outstanding (Basic)261.80M269.60M−2.9%
Shares Outstanding (Diluted)266.80M274.60M−2.8%

Frequently Asked Questions

  1. What was the primary driver of the net sales increase in the second quarter and first half of 2015?

    The primary drivers of the net sales increase were higher product volumes sold across most segments and a favorable price/product mix. Recent acquisitions, specifically the Lil' Drug Store Brands (LDS) and Varied Industries Corporation (VI-COR), also contributed to the top-line growth.

  2. What factors impacted the company's gross margin?

    The gross margin in the second quarter of 2015 saw a slight decrease primarily due to higher manufacturing costs, including start-up costs for the new vitamin manufacturing facility, and unfavorable foreign exchange rates. These were partially offset by lower commodity costs, productivity programs, and a favorable impact from recent acquisitions.

  3. What significant non-operational items affected the company's earnings?

    A significant non-operational item was a $17.0 million impairment charge recorded on the company's remaining investment in the Natronx joint venture. Additionally, an $8.9 million charge related to the settlement of an international pension plan impacted SG&A expenses.

  4. How did the company manage its cash flow and liquidity?

    The company generated strong operating cash flow, which increased significantly in the first half of 2015. This cash flow, along with available credit facilities, is expected to be sufficient to fund capital expenditures, dividends, share repurchases, and debt obligations. The company also repatriated $93.0 million in cash from foreign subsidiaries.